Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm

Gynecologic Oncology

Volumn 127, Issue 3, 2012, Pages 556-563

  Brain, Kate E ^a   Lifford, Kate J ^a   Fraser, Lindsay ^b   Rosenthal, Adam N ^b,c   Rogers, Mark T ^a   Lancastle, Deborah ^d   Phelps, Ceri ^e   Watson, Eila K ^f   Clements, Alison ^g   Menon, Usha ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF GLAMORGAN   (United Kingdom)

^e Swansea Metropolitan University   (United Kingdom)

^f OXFORD BROOKES UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Genetic risk; Ovarian cancer; Psychological outcomes; Risk management; Screening

Indexed keywords

CA 125 ANTIGEN;

ADULT; ANXIETY; ARTICLE; CANCER SCREENING; DEMOGRAPHY; DEPRESSION; EMOTIONAL STRESS; FAMILIAL CANCER; FAMILIAL OVARY CANCER; FEMALE; FOLLOW UP; GENE MUTATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; TIME FACTORS;

EID: 84868550186     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.08.034     Document Type: Article

References (30)

1. Cancer Research UK Ovarian cancer - UK Available at http://info. cancerresearchuk.org/cancerstats Last accessed 21 May 2012
2. American Cancer Society Ovarian cancer Available at: www.cancer.org Last accessed 21 May 2012
3. R. Angioli, R. Estape, M. Mason, and M. Penalver Hereditary and sporadic ovarian cancer: genetic testing and clinical implications Int J Oncol 12 1998 1029 1034
4. N.D. Kauff, J.M. Satagopan, M.E. Robson, L. Scheuer, M. Hensley, and C.A. Hudis Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 21 2002 1609 1615
5. T.R. Rebbeck, H.T. Lynch, S.L. Neuhausen, S.A. Narod, L. Van't Veer, and J.E. Garber Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 21 2002 1616 1622
6. N.D. Kauff, S.M. Domchek, T.M. Friebel, M.E. Robson, J. Lee, and J.E. Garber Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynaecologic cancer: a multicenter, prospective study J Clin Oncol 26 8 2008 1331 1337
7. M. Robson, M. Hensley, R. Barakat, C. Brown, D. Chi, and E. Povnor Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy Gynecol Oncol 89 2 2003 281 287
8. Rosenthal AN, Fraser L, Manchanda R, Badman P, Philpott S, Mozersky J, et al. Results of annual screening in the UK Familial Ovarian Cancer Screening Study (UK FOCSS Phase 1) highlight need for strict adherence to screening schedule. J Clin Oncol in press.
9. M.L. Hensley, M.E. Robson, N.D. Kauff, B. Korvtowsky, M. Castiel, and J. Ostroff Pre- and post-menopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life Gynecol Oncol 89 3 2003 440 446
10. S.J. Skates, U. Menon, N. MacDonald, A.N. Rosenthal, D.H. Oram, and R.C. Knapp Calculation of risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women J Clin Oncol 21 10 Suppl. 2003 206s 210s
11. A.R. Aro, S. Pilvikki Absetz, T.M. van Elderen, E. van der Ploeg, and L.J. van der Kamp False-positive findings in mammography screening induces short-term distress - breast cancer-specific concern prevails longer Eur J Cancer 36 9 2000 1089 1097
12. J. Brett, and J. Austoker Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors influencing re-attendance J Public Health Med 23 4 2001 292 300
13. J. Wardle, W. Collins, A. Pernet, M.I. Whitehead, T.H. Bourne, and S. Campbell Psychological impact of screening for familial ovarian cancer J Natl Cancer Inst 85 8 1993 653 657
14. N.D. Kauff, K.E. Hurley, M.L. Hensley, M.E. Robson, G. Lev, and D. Goldfrank Ovarian carcinoma screening in women at intermediate risk Cancer 104 2 2005 314 320
15. J. Wardle, A. Pernet, W. Collins, and T. Bourne False positive results in ovarian cancer screening: one year follow-up of psychological status Psychol Health 10 1 1994 33 40
16. M.A. Andrykowski, L.M. Boerner, J.M. Salsman, and E. Pavlik Psychological response to test results in an ovarian cancer screening program: a prospective, longitudinal study Health Psychol 23 6 2004 622 630
17. M.R. Andersen, C.W. Drescher, Y. Zheng, D.J. Bowen, S. Wilson, and A. Young Changes in cancer worry associated with participation in ovarian cancer screening Psychooncology 16 2007 814 820
18. K.J. Lifford, L. Fraser, A. Rosenthal, U. Menon, M. Rogers, and D. Lancastle Withdrawal from familial ovarian cancer screening: preliminary findings from a psychological evaluation study Gynecol Oncol 124 2012 158 163
19. D. Lancastle, K. Brain, and C. Phelps Illness representations and distress in women undergoing screening for familial ovarian cancer Psychol Health Jul 7 2011 10.1080/08870446.2011.555544 [Epub ahead of print]
20. M. Horowitz, N. Wilner, and W. Alvarez Impact of Event Scale: a measure of subjective stress Psychosom Med 41 1979 209 218
21. M. Horowitz Stress response syndromes and their treatment L. Goldberger, S. Breznitz, Handbook of stress: theoretical and clinical aspects 1982 Free Press New York 71 732
22. G. Kent, H. Howie, F. Fletcher, R. Newbury-Ecob, and K. Hosie The relationship between perceived risk, thought intrusiveness and emotional well-being in women receiving counselling for breast cancer risk in a family historic clinic Br J Health Psychol 5 2000 15 26
23. K. Tiller, B. Meiser, P. Butow, M. Clifton, B. Thewes, and M. Friedlander Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study Gynecol Oncol 86 2 2002 212 219
24. B. Thewes, B. Meiser, and I.B. Hickie Psychometric properties of the Impact of Event Scale amongst women at increased risk of hereditary breast cancer Psychooncology 10 2001 459 468
25. A.S. Zigmond, and R.P. Snaith The Hospital Anxiety and Depression Scale Acta Psychiatr Scand 67 1983 361 370
26. S. van Dooren, A.J. Rijnsburger, C. Seynaeve, H.J. Duivenvoorden, M.L. Essink-Bot, and M.M. Tilanus-Linthorst Psychological distress in women at increased risk for breast cancer: the role of risk perception Eur J Cancer 40 14 2004 2056 2063
27. S. Tyndel, B. Henderson, J. Austoker, K. Brain, C. Bankhead, and A. Clements What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS management group J Clin Oncol 25 2007 3823 3830
28. A. Clements, B.J. Henderson, S. Tyndel, G. Evans, K. Brain, and J. Austoker Diagnosed with breast cancer while on a family history screening programme: an exploratory qualitative study Eur J Cancer Care 17 3 2008 245 252
29. S.M. Miller, P. Roussi, M.B. Daly, and J. Scarpato New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy Clin Cancer Res 16 21 2010 5094 5106
30. J. Witt, G. Elwyn, F. Wood, and K. Brain Decision making and coping in healthcare: the Coping in Deliberation (CODE) Framework Patient Educ Couns 2012 http://dx.doi.org/10.1016/j.pec.2012.03.002 [Electronic publication ahead of print]